- Wealth
- ₹1,200 Cr
- Company
- Medley Pharmaceuticals
About Sahir Sami Khatib
Data last updated:
Sahir Sami Khatib is a Partner at Alpha Alternatives Msar Llp (since 2021), Managing Director at Medley Pharmaceuticals Limited (since 2015) and Director at Blue-Fin Frozen Foods Private Limited (since 2010), and holds 8 more current directorships. The companies operate in Financial Services, Pharma and Food and Beverages. The 11 current companies with reported revenue have a combined latest revenue of ₹5,732 Cr; the largest is Alpha Alternatives Msar Llp at ₹4,486 Cr (FY 2025). Earlier, Sahir Sami Khatib was an Additional Director at Vivomed Private Limited (2009–2022) and Director at Sinkhai Healthcare Limited (2005–2016) and 3 more.
Sahir Khatib is #1,608 among India's richest people (2026), with wealth of ₹1,200 Cr.
Recognitions & Rankings
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Partner | 02 Aug 2021 | 2021 | ₹4,486 Cr (FY 2025) | Active | |
| Managing Director | 01 Apr 2015 | 1975 | ₹1,115 Cr (FY 2025) | Active | |
| Director | 15 Jun 2010 | 2008 | ₹118 Cr (FY 2025) | Active | |
| Managing Director | 17 Aug 1995 | 1985 | ₹12.23 Cr (FY 2025) | Active | |
| Director | 14 Aug 2000 | 1982 | ₹62.5 Lakh (FY 2017) | Active | |
| Director | 06 Jan 1988 | 1983 | ₹31.2 Lakh (FY 2025) | Active | |
| Director | 16 May 2023 | 1979 | ₹29.7 Lakh (FY 2025) | Active | |
| Director | 15 Apr 1997 | 1985 | ₹16.8 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 27 Jan 2009 | 1979 | Active | ||
| Director | 14 Mar 2005 | 2005 | ₹145 Cr (FY 2025) | Active | |
| Director | 01 Sep 1998 | 1997 | ₹29.92 Cr (FY 2025) | Active | |
| Director | 09 Feb 2009 | 1975 | Amalgamated | ||
| Nominee Director | 01 Nov 2011 | 1983 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sahir Sami Khatib
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sahir Sami Khatib
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sahir Sami Khatib
Sahir Sami Khatib currently holds 11 directorships: Alpha Alternatives Msar Llp (Partner, since 02 Aug 2021, revenue ₹4,486 Cr (FY 2025)); Medley Pharmaceuticals Limited (Managing Director, since 01 Apr 2015, revenue ₹1,115 Cr (FY 2025)); Blue-Fin Frozen Foods Private Limited (Director, since 15 Jun 2010, revenue ₹118 Cr (FY 2025)); Masiha Medica Pvt Ltd (Managing Director, since 17 Aug 1995, revenue ₹12.23 Cr (FY 2025)); Minar Chemicals Pvt Ltd (Director, since 14 Aug 2000, revenue ₹62.5 Lakh (FY 2017)); and 6 more.
Sahir Sami Khatib was first appointed on 06 Jan 1988 as Director at Sorbo Monni Chemicals Private Limited. The most recent appointment on record is 16 May 2023 at Sinkhai Ventures Private Limited.
The 11 current companies of Sahir Sami Khatib that report revenue have a combined latest revenue of ₹5,732 Cr: Alpha Alternatives Msar Llp ₹4,486 Cr (FY 2025); Medley Pharmaceuticals Limited ₹1,115 Cr (FY 2025); Blue-Fin Frozen Foods Private Limited ₹118 Cr (FY 2025); Masiha Medica Pvt Ltd ₹12.23 Cr (FY 2025); Minar Chemicals Pvt Ltd ₹62.5 Lakh (FY 2017); and 6 more.
Sahir Sami Khatib held 5 earlier board appointments: Vivomed Private Limited (Additional Director, 27 Jan 2009 to 20 Sep 2022); Sinkhai Healthcare Limited (Director, 14 Mar 2005 to 09 Dec 2016); Steranco Healthcare Private Limited (Director, 01 Sep 1998 to 24 Oct 2016); Medley Laboratories Private Limited (Director, from 09 Feb 2009); Standard Precious Alloy Industries Private Limited (Nominee Director, from 01 Nov 2011).
The current boards of Sahir Sami Khatib's companies include Mudit Singhania (Alpha Alternatives Msar Llp), Shreyans Hitendrakumar Mehta (Alpha Alternatives Msar Llp), Devendra Pandurang Bhagat (Medley Pharmaceuticals Limited), Mirasif Mirmohsin Ali (Medley Pharmaceuticals Limited), Mohamed Aslam Abdul Rahman Sheikh (Medley Pharmaceuticals Limited), Ravindra Baliram More (Medley Pharmaceuticals Limited), among others.